Delivery Order SPE2DB20D3104-SPE2DB25FV9Y9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units) with a ceiling value of $14,764.20. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the open competition...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count) with a ceiling value of $1,512.73. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units) with a ceiling value of $3,721.27. This is a firm fixed-price delivery order with an ultimate completion date of April 24, 2025, with performance to be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract was competitively awarded with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mesalamine DR 1.2 GM tablets (120 count) on August 29, 2025, with a ceiling value of $1,419.34 and completion deadline of September 2, 2025. This firm fixed-price delivery order was awarded without set-aside restrictions through open competition. The order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units) under a firm fixed-price contract valued at $3,286.98, with ultimate completion scheduled for September 15, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency (DLA) awarded a $1,694.97 delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count unit) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count packaging) under a firm fixed-price contract valued at $1,014.56. This non-set-aside delivery order represents a small-value pharmaceutical procurement with a completion date of July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units) with a ceiling value of $14,323.16. This firm fixed-price delivery order, which is expected to be completed by August 6, 2025, represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count) at a contract ceiling value of $1,836.05. This firm fixed price delivery order, which is not set-aside designated, is scheduled for ultimate completion on May 7, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,803.07 on September 15, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120 count). This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania, and an ultimate completion date of September 16, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FV9Y9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mesalamine DR 1.2 GM tablets in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $1,556.04, with an ultimate completion date of September 4, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The pharmaceutical supply supports the Defense Health Agency and other federal healthcare systems, with Mesalamine being a gastrointestinal therapeutic medication commonly used in military and veteran healthcare settings.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/3/25 |